External Validation of the DAPT Score in a Nationwide Population-Reference-Cited by-同舟云学术

External Validation of the DAPT Score in a Nationwide Population

Published:2018-09 Issue:10 Volume:72 Page:1069-1078
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ueda Peter,Jernberg Tomas,James Stefan,Alfredsson Joakim,Erlinge David,Omerovic Elmir,Persson Jonas,Ravn-Fischer Annica,Tornvall Per,Svennblad Bodil,Varenhorst Christoph

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014

2. Long-term use of ticagrelor in patients with prior myocardial infarction;Bonaca;N Engl J Med,2015

3. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur Heart J,2017

5. Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents;Matteau;Am J Cardiol,2015

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

2. Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample;Journal of Clinical Medicine;2024-05-11

3. Dynamic Prognosis Prediction for Patients on DAPT After Drug‐Eluting Stent Implantation: Model Development and Validation;Journal of the American Heart Association;2024-02-06

4. Fully independent external validation of the Transcatheter Aortic Valve Replacement 30-day (TAVR-30) hospital readmission model;Cardiovascular Revascularization Medicine;2023-11

5. Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review;Pharmacogenomics and Personalized Medicine;2023-11